|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 5.050 USD | +36.12% |
|
+22.87% | -8.18% |
| 10-16 | Adial Pharmaceuticals, Inc. Announces Appointment of David Rubenstein, M.D., Ph.D. as Chief Scientist | CI |
| 09-18 | Adial Pharmaceuticals Announces Board Appointments | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADIL | Delayed | |
CBOE
| ADIL | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 5.24 | 7.12 | 7.84 |
| Spread/Res. | -3.63% | -29.07% | -35.59% |
| Spread/Supp. | +25.94% | +69.46% | +265.94% |
| Support | 4.01 | 2.98 | 1.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADIL Stock
- Charts Adial Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
